Nanobiotix is trading 8.3% down at $39.95 amid broader risk-off pressure, with no fresh company-specific announcement or analyst action identified for August 24, 2026.
- Its investor-relations page shows the latest indexed update dated July 30, rather than a new August 24 catalyst.
- The Nasdaq Composite is down 0.68% as investors weigh sanctions, trade tensions, elevated oil prices, and high Treasury yields.
- The loss is substantially larger than major-index moves, so the explanation remains tentative.